Real-world patient insights,
delivered in one connected platform

Healthcare providers discussing a patient care plan in a clinic setting at Blue Charm in Nova Scotia, Canada

See the Blue Charm Program in Action

Real World Data. Real People. Real Impact.

The Blue Charm Program

One integrated program that unites adherence data with patient engagement insights to measure treatment effectiveness, improving access and outcomes

Patient-Centered Design

Programs that engage and reward patients, ensuring higher completion rates and refined data.

Scalable Deployment

Deploy across any therapeutic area with flexible, customizable programs

Secure and Compliant

Data integrity, privacy, and security built into every step of the process

How It Works

From patient enrollment to outcomes reporting, the Blue Charm Program is built to scale.

Launch

Together, we identify your challenges and create a tailored program that addresses patient needs and supports your brand objectives. Whether you choose a financial assistance program, patient engagement, or both, we are here to tailor our program towards your needs.

Engage

Patients receive their financial assistance card to use at the pharmacy and can access the Blue Charm app through their phone to engage in surveys and learning modules.

Capture

We collect structured insight across the entire patient journey, combining real‑world prescription behaviour with direct patient experience insights.

Analyze

Our platform uses advanced analytics and reporting tools to provide life sciences companies with actionable insights that are updated in real-time. The data is structured, anonymized, and visualized in one single source for your team. 

Act

Teams are empowered to optimize programs, inform field activity, and make confident, evidence‑based decisions.

Patient Engagement

Capturing the
Patient Voice

Our Blue Charm app captures the patient voice, turning lived experiences into structured data. Patients complete surveys and learning modules, while brands access a continuous stream of insights.

  • 80% re-engagement rate, 8x higher than other health apps
  • Flexible platform customized to brand goals
  • Longitudinal insights across the patient journey
  • Dynamic question pathways for deeper perspectives
  • Real-world data that is geographically and demographically diverse
Financial Assistance

Understanding
Prescription Behaviour

The Blue Charm financial assistance card helps reduce cost barriers at the pharmacy while generating real-world prescription behaviour insight across the patient journey.

  • Reduced out-of-pocket expenses through financial assistance program
  • Seamless use at pharmacies
  • Clear visibility into support received
  • Instant downloadable cards
  • Adjustable program parameters throughout patient journey
  • No vendor dependency or operational delays
  • Provides brands full ownership of their support strategy
  • Real-time dashboards tracking card activation, usage, and refill behaviour
  • Longitudinal insights across medications
  • Secure access to data to support monitoring and optimization
  • Scalable across a single brand or an entire portfolio
  • Suitable for launch, growth, and mature products
  • Configurable reporting aligned to client priorities

Life sciences teams can leverage program data to:

  • Inform launch and lifecycle strategy
  • Support field conversations with evidence‑based insights
  • Identify high‑risk drop‑off windows earlier
  • Generate publishable real‑world evidence

Use Cases

Commercial

  • How does the decision criteria to initiate therapy differ by province?
  • What percentage of patients felt like their disease was better managed after switching to Drug A?

Medical Affairs

  • Which age group experiences the greatest impact of Drug A on disease progression?
  • How does Drug A compare to Drug B on negative side effects?

Patient Services

  • What part of the PSP is least important to MS patients?
  • What additional PSP service would be most valued by patients in British Columbia?

Market Access

  • What’s the public/private/cash payer split for Drug A in Ontario?
  • How do co-pay amounts differ between patients with public vs. private plans?